Confidentiality and the Role of the Addiction Specialist Team in Liver Transplantation Procedures. Commentary on Donnadieu-Rigole et al., 2017, Follow-Up of Alcohol Consumption After Liver Transplantation: Interest of an Addiction Team?

Dom, Geert

doi:10.1111/acer.13324

Cited by 3 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An independent, confidential, and specialised addiction management enables for focus on the chronic brain disease. 29 , 30 Specific pharmacological and non-pharmacological interventions are proposed and adapted to the situation. The LT patient is thus financial support in their chronic addictive disease and is not hampered by the denial that could arise regarding his ‘saviour’, the transplant surgeon.…”

Section: Discussionmentioning

confidence: 99%

Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse

et al. 2023

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse

et al. 2023

View full text Add to dashboard Cite

“…Patients should receive assistance to access services that can improve posttransplant adherence (including addictions treatment and counseling). 76 , 77 Also, given the potential risk of relapse after the transplantation, it is important that patients have access to addiction services to reduce this risk. However, not all Canadian transplant programs currently have the resources and expertise to support and assess patients with cannabis and alcohol use disorder.…”

Section: Introductionmentioning

confidence: 99%

Canadian Society of Transplantation White Paper: Ethical and Legal Considerations for Alcohol and Cannabis Use in Solid Organ Listing and Allocation

et al. 2021

View full text Add to dashboard Cite

Alcohol and cannabis use as a contraindication to organ transplantation is a controversial issue. Until recently, patients in Canada with alcohol-associated liver disease were required to demonstrate abstinence for 6 mo to receive a liver transplant. There is no equivalent rule that is applied consistently for cannabis use. There is some evidence that alcohol and cannabis use disorder pretransplant could be associated with worse outcomes posttransplantation. However, early liver transplantation for patients with alcohol-associated liver disease in France and in the United States has led to challenges of the 6-mo abstinence rule in Canada in the media. It has also resulted in several legal challenges arguing that the rule violates human rights laws regarding discrimination in the provision of medical services and that the rule is also unconstitutional (this challenge is still before the court). Recent legalization of cannabis use for adults in Canada has led to questions about the appropriateness of limiting transplant access based on cannabis use. The ethics committee of the Canadian Society of Transplantation was asked to provide an ethical analysis of cannabis and alcohol abstinence policies. Our conclusions were as follows: neither cannabis use nor the 6-mo abstinence rule for alcohol use should be an absolute contraindication to transplantation, and transplant could be offered to selected patients, further research should be conducted to ensure evidence-based policies; and the transplant community has a duty not to perpetuate stigma associated with alcohol and cannabis use disorders.

show abstract

Post-transplant Psychosocial and Mental Health Care of the Liver Recipient

DiMartini

Golden

Matz

et al. 2018

Psychosocial Care of End-Stage Organ Disease and Transplant Patients

View full text Add to dashboard Cite

Confidentiality and the Role of the Addiction Specialist Team in Liver Transplantation Procedures. Commentary on Donnadieu-Rigole et al., 2017, Follow-Up of Alcohol Consumption After Liver Transplantation: Interest of an Addiction Team?

Cited by 3 publications

References 22 publications

Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse

Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse

Canadian Society of Transplantation White Paper: Ethical and Legal Considerations for Alcohol and Cannabis Use in Solid Organ Listing and Allocation

Post-transplant Psychosocial and Mental Health Care of the Liver Recipient

Contact Info

Product

Resources

About